Chelation, A Potentially Lifesaving Therapy

Listen to the Intelligent Medicine podcast with Dr. Ronald Hoffman and hear TACT2 investigator Dr. Dana Cohen describe the TACT2 trial, a multi-million dollar government-sponsored study to evaluate the effectiveness of chelation therapy. What is chelation? What is its history? How did the first TACT study demonstrate its effectiveness? Why was it greeted with skepticism by the medical establishment? Why have only integrative doctors been eager to embrace chelation?

Part 1

Part 2

Ensayo clínico busca beneficios en pacientes diabéticos

9/29/2016 – The National Center for Complementary and Integrative Health (NCCIH) que forma parte de los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) ha otorgado $37M a Mount Sinai Medical Center de la Florida y al Duke Clinical Research Institute para dar comienzo al segundo Ensayo Clínico que Evalúa la Terapia de Quelación (TACT2).

In the News

  • TACTful Perseverance and a Black Swan Event Tactful Perseverance and a Black Swan Event –TACT2 to follow-up on post-MI diabetic patients. “I have to admit that until 1999, I had no particular interest in studying a pariah therapy called EDTA chelation — really just not my style.” // “When the Duke staff distributed the previously blinded analyses, all of us turned to the bottom line, ... more